Dilated cardiomyopathy (DCM) is a cardiac muscle disease with reduced left ventricular systolic function[1]. Myocardial inflammation is the most common mechanism in the pathogenesis of cardiomyopathy in which cytokines may play an important role[2]. The objective of this study was to investigate the associations between tumor necrosis factor-alpha (TNF-α, -308), transforming growth factor-beta 1 (TGF-β1, +10, +25), interleukin-10 (IL-10, -1082, -819, and -592), interleukin-6 (IL-6, -174), interferon-gamma (IFN-γ, +874) gene polymorphisms and DCM.
Sixteen children with DCM (3 months-13 years) and 21 healthy controls were tested for the cytokine genes with polymerase chain reaction-sequence-specific primers (PCR-SSP). In our results, TNF-α (-308) A allele was higher in DCM (P=0.03). The frequency of TNF-α (-308) GG genotype (low expression) was significantly decreased in DCM (P=0.02). The children with DCM had significantly higher frequencies of IFN-γ (+874) TT genotype (high expression) and allele T while TA genotype (intermediate expression) was lower in patients (P=0.003, P=0.01 and P=0.04, respectively). Haplotype analyses showed that TT/GG and TC/GG ha plotypes of TGF-β1 (high expression) were significantly decreased while TC/GC, CC/GG and TT/GC (intermediate expression) haplotypes were increased (P=0.01 and P=0.04, respectively). There was no association between IL-6 and IL-10 genotypes/haplotypes and DCM (P>0.05).
TNF-α is a strong proinflammatory and immunomodulatory cytokine that intervenes inflammatory diseases and is produced by activated macrophages[3]. Frequency of TNF-α allele A was found high in DCM[4]. TNF-α allele A (-308) was found over-expressed in patients with end-stage non-ischemic myocardial dysfunction[5]. Tired et al did not find any association between TNF-α (-308) polymorphism and DCM[6]. In our study, allele A of TNF-α (-308) gene was found susceptible to DCM, while GG genotype of TNF-α (-308) showed a protective effect against the disease.
The production or activities of several cytokines are modulated by IFN-γ[7]. The AA homozygosity of IFN-γ (+874) T/A polymorphism was associated with poor prognosis in idiopathic DCM in older patients[2]. IFN-γ protected against the development of severe chronic myocarditis, pericarditis, and DCM after Coxackievirus B3 infection by reducing mast cell degranulation, and the profibrotic cytokines (IL-4, IL-1β, TGF-β1) in the heart[8]. In our study, the high expression of IFN-γ was found susceptible to DCM. We hypothesized that IFN-γ might play a possible role in the immuno-inflammatory process of childhood DCM, although it is not clear whether these act to preserve or protect against further inflammatory injury.
IL-6 is one of the proinflammatory cytokines with many systemic effects, including cardiovascular system[9]. The GG and GC genotypes of IL-6 (-174) are associated with increased levels of IL-6, while CC with decreased expression[10]. IL-6 levels were significantly associated with all outcomes of heart disease in adults[11]. IL-6 (-174) polymorphism was associated with LVESD and LVEDD in DCM[8]. Although allele C was higher in our patient group, there was borderline statistical significance between the groups (P=0.0590).
IL-10 is a regulatory cytokine which inhibits the production of IFN-γ and TNF-α and antagonizes the proinflammatory cytokine response[12]. The diagnosis of DCM has been associated with a reduction in IL-10 plasma levels, indicating its protective role in cytokine activation[13]. However, recent studies have suggested that IL-10 polymorphisms are not associated with DCM[2, 4], in agreement with our results.
TGF-β1 is an anti-inflammatory cytokine that might play a major role in the immune modulation of heart function[6]. TGF-β1 expression is increased in the myocardium of patients with DCM[14]. TGF-β1 polymorphisms were correlated with better exercise capacity, and heart failure symptoms[2]. Tiret et al found no relationship between TGF-β1 gene polymorphism and DCM[6]. This study indicates that the high expression of TGF-β1 had a protective effect against the DCM, while intermediate expression had susceptibility to the disease. Fairweather et al reported that IFN-γ protected against the development of DCM after infection by reducing profibrotic cytokines like TGF-β1[8].
We conclude that the increase in the expression of IFN-γ and TNF-α genes may be associated with the etiopathogenesis of DCM; however, the increase in the expression of TGF-β1 gene may play a protective role against the development of this disease.
References
- 1.Nugent AW, Daubeney DE, Chandras P, et al. The epidemiyology of childhood cardiomiyopathy in Australia. N Engl J Med. 2003;348(17):1639–46. doi: 10.1056/NEJMoa021737. [DOI] [PubMed] [Google Scholar]
- 2.Adamopoulos S, Kolokathis F, Gkouziouta A, et al. Cytokine gene polymorphisms are associated with markers of disease severity and prognosis in patients with idiopathic dilated cardiomyopathy. Cytokine. 2011;54(1):68–73. doi: 10.1016/j.cyto.2011.01.004. [DOI] [PubMed] [Google Scholar]
- 3.Vadlamani L, Iyengar S. Tumour necrosis factor α polymorphism in heart failure/cardiomyopathy. Congest Heart Fail. 2004;10(6):289–92. doi: 10.1111/j.1527-5299.2004.02020.x. [DOI] [PubMed] [Google Scholar]
- 4.Ito M, Takahashi H, Fuse K, et al. Polymorphisms of tumor necrosis factor-α and interleukin 10 genes in Japanese patients with idiopathic dilated cardiomyopathy. Jpn Heart J. 2000;41(2):83–91. doi: 10.1536/jhj.41.183. [DOI] [PubMed] [Google Scholar]
- 5.Densem CG, Hutchinson IV, Yonan N, et al. Tumor necrosis factor alpha gene polymorphism: a predisposing factor to non-ischaemic myocardial dysfunction? Heart. 2002;87(2):153–5. doi: 10.1136/heart.87.2.153. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Tiret L, Mallet C, Poirier O, et al. Lack of association between polymorphisms of eight candidate genes and idiopathic dilated cardiomyopathy. J Am Coll Cardiol. 2000;35(1):29–35. doi: 10.1016/s0735-1097(99)00522-7. [DOI] [PubMed] [Google Scholar]
- 7.Schroder K, Hertzog PJ, Ravasi T, et al. Interferon-gamma: an overview of signals, mechanisms and functions. J Leukoc Biol. 2004;75(2):163–89. doi: 10.1189/jlb.0603252. [DOI] [PubMed] [Google Scholar]
- 8.Fairweather D, Frisancho-Kiss S, Yusung SA, et al. Interferon-γ protects against chronic viral myocarditis by reducing mast cell degranulation, fibrosis, and the profibrotic cytokines transforming growth factor-β1, interleukin-1 β, and interleukin-4 in the heart. Am J Pathol. 2004;165(6):1883–94. doi: 10.1016/s0002-9440(10)63241-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Fonseca JE, Santos MJ, Canhao H, et al. Interleukin-6 as a key player in systemic inflammation and joint destruction. Autoimmun Rev. 2009;8(7):538–42. doi: 10.1016/j.autrev.2009.01.012. [DOI] [PubMed] [Google Scholar]
- 10.Fishman D, Faulds G, Jeffery R, et al. The effect of novel polymorphism in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic onset juvenile chronic arthritis. J Clin Invest. 1998;102(7):1369–76. doi: 10.1172/JCI2629. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Cesari M, Penninx BW, Newman AB, et al. Inflammatory markers and onset of cardiovascular events: result from the health ABC study. Circulation. 2003;108(19):2317–22. doi: 10.1161/01.CIR.0000097109.90783.FC. [DOI] [PubMed] [Google Scholar]
- 12.Couper KN, Blount DG, Riley EM. Il-10: The master regulator of immunity to infection. J Immunol. 2008;180(9):5771–7. doi: 10.4049/jimmunol.180.9.5771. [DOI] [PubMed] [Google Scholar]
- 13.Adamopoulos S, Parissis JT, Paraskevaidis I, et al. Effects of growth hormone on circulating cytokine network, and left ventricular contractile performance and geometry in patients with idiopathic dilated cardiomyopathy. Eur Heart J. 2003;24(24):2186–96. doi: 10.1016/s0195-668x(03)00480-9. [DOI] [PubMed] [Google Scholar]
- 14.Aharinejad S, Krenn K, Paulus P, et al. Differantial role of TGF-β1/bFGF and ET-1 in graft fibrosis in heart failure patients. Am J Transplant. 2005;5(9):2185–92. doi: 10.1111/j.1600-6143.2005.01006.x. [DOI] [PubMed] [Google Scholar]